962 related articles for article (PubMed ID: 26124236)
21. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement.
Cohen D; Rijnink EC; Nabuurs RJ; Steup-Beekman GM; Versluis MJ; Emmer BJ; Zandbergen M; van Buchem MA; Allaart CF; Wolterbeek R; Bruijn JA; van Duinen SG; Huizinga TW; Bajema IM
Rheumatology (Oxford); 2017 Jan; 56(1):77-86. PubMed ID: 28028157
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
24. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
25. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
Ferreira I; Croca S; Raimondo MG; Matharu M; Miller S; Giles I; Isenberg D; Ioannou Y; Hanly JG; Urowitz MB; Anderson N; Aranow C; Askanase A; Bae SC; Bernatsky S; Bruce IN; Buyon J; Clarke AE; Dooley MA; Fortin P; Ginzler E; Gladman D; Gordon C; Inanc M; Jacobsen S; Kalunian K; Kamen D; Khamashta M; Lim S; Manzi S; Merrill J; Nived O; Peschken C; Petri M; Ramsey-Goldman R; Ruiz-Irastorza G; Sanchez-Guerrero J; Steinson K; Sturfelt GK; van Vollenhoven R; Wallace DJ; Zoma A; Rahman A
Arthritis Res Ther; 2017 Dec; 19(1):287. PubMed ID: 29273092
[TBL] [Abstract][Full Text] [Related]
26. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
27. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre.
Bortoluzzi A; Padovan M; Farina I; Galuppi E; De Leonardis F; Govoni M
Reumatismo; 2012 Dec; 64(6):350-9. PubMed ID: 23285478
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study.
Ahn GY; Kim D; Won S; Song ST; Jeong HJ; Sohn IW; Lee S; Joo YB; Bae SC
Lupus; 2018 Jul; 27(8):1338-1347. PubMed ID: 29688144
[TBL] [Abstract][Full Text] [Related]
30. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
31. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
[TBL] [Abstract][Full Text] [Related]
32. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
Sibbitt WL; Schmidt PJ; Hart BL; Brooks WM
J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
[TBL] [Abstract][Full Text] [Related]
33. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
[TBL] [Abstract][Full Text] [Related]
34. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
36. Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus.
Zervides KA; Janelidze S; Nystedt J; Gullstrand B; Nilsson P; Sundgren PC; Bengtsson AA; Hansson O; Jönsen A
BMC Neurol; 2022 Dec; 22(1):467. PubMed ID: 36494778
[TBL] [Abstract][Full Text] [Related]
37. Diminished white matter integrity in patients with systemic lupus erythematosus.
Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
[TBL] [Abstract][Full Text] [Related]
38. Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE.
Liu GY; Utset TO; Bernard JT
Lupus; 2015 Oct; 24(11):1169-76. PubMed ID: 25888613
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
40. Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Hori H; Umene-Nakano W; Katsuki A; Saito K; Tanaka Y; Nakamura J
Hum Psychopharmacol; 2013 Mar; 28(2):198-202. PubMed ID: 23532751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
